Kyoto, Japan

Yoshimichi Shoji


 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2018-2022

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations of Yoshimichi Shoji

Introduction

Yoshimichi Shoji is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anticancer agents. With a total of six patents to his name, his work has the potential to impact cancer treatment significantly.

Latest Patents

Among his latest patents is an anticancer agent that addresses the need for a useful prodrug compound of a naphthofuran compound. This invention relates to a compound represented by a specific formula, which includes pharmaceutically acceptable salts. Another notable patent is for a cyclin-dependent kinase 8 and/or 19 inhibitor, which aims to provide a novel agent useful as an anti-cancer treatment. This invention also includes a compound represented by a specific formula, serving as an active ingredient for preventing and/or treating cancer.

Career Highlights

Yoshimichi Shoji has worked with reputable companies in the pharmaceutical industry, including Kyoto Pharmaceutical Industries, Ltd. and Sumitomo Dainippon Pharma Co., Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Throughout his career, Yoshimichi has collaborated with notable colleagues such as Shigemitsu Takeda and Yoshinobu Yoshimura. These partnerships have likely enhanced his research and development efforts in the pharmaceutical field.

Conclusion

Yoshimichi Shoji's contributions to cancer treatment through his innovative patents highlight his importance in the pharmaceutical industry. His work continues to pave the way for advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…